Central hyperthyroidism
- PMID: 9534036
- DOI: 10.1016/s0889-8529(05)70306-6
Central hyperthyroidism
Abstract
Central hyperthyroidism is a rare condition in which thyrotoxicosis results from primary overproduction of TSH by the pituitary gland with subsequent thyroid enlargement and hyperfunction. The two known causes of central hyperthyroidism are TSH-producing pituitary tumors (TSHomas) and the syndrome of PRTH. Both of these entities are characterized by clinical thyrotoxicosis, diffuse goiters, elevated circulating levels of free T4 and T3, and a nonsuppressed serum TSH. It is critical to distinguish central hyperthyroidism from the much more common types of primary hyperthyroidism, all of which have undetectable TSH values. TSHomas and PRTH can usually be differentiated from one another by measuring the serum alpha-subunit and the TSH response to intravenous TRH or exogenous thyroid hormone, and by pituitary imaging studies. TSHomas are usually benign adenomas arising from the monoclonal expansion of neoplastic thyrotropes. Causative oncogenes have not yet been convincingly identified. PRTH is a nonneoplastic disorder caused by inherited mutations in the gene for the thyroid hormone receptor beta; it is a poorly understood variant of GRTH. For unclear reasons, in PRTH, the pituitary gland is resistant to the feedback inhibitory effects of circulating thyroid hormones while peripheral tissues respond normally, causing patients to experience the toxic peripheral effects of thyroid hormone excess. TSHomas are best treated by transphenoidal surgical removal. Radiotherapy is indicated for inoperable or incompletely resected tumors. Octreotide administration is a useful adjunct for preoperatively reducing tumor size and for the medical management of surgical treatment failures. PRTH is ideally treated by chronically suppressing TSH secretion with medications such as D-thyroxine, TRIAC, octreotide, or bromocriptine. If such therapy is ineffective or unavailable, thyroid ablation with radioiodine or surgery may be employed with subsequent close monitoring of both thyroid hormone status and pituitary gland size.
Similar articles
-
Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.Acta Endocrinol (Copenh). 1985 Nov;110(3):373-82. doi: 10.1530/acta.0.1100373. Acta Endocrinol (Copenh). 1985. PMID: 3934894
-
Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma.Endocr J. 2000 Dec;47(6):731-8. doi: 10.1507/endocrj.47.731. Endocr J. 2000. PMID: 11228048
-
Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.Clin Endocrinol (Oxf). 2005 Feb;62(2):176-81. doi: 10.1111/j.1365-2265.2004.02192.x. Clin Endocrinol (Oxf). 2005. PMID: 15670193
-
A thyrotropin-secreting macroadenoma with positive growth hormone and prolactin immunostaining: A case report and literature review.Niger J Clin Pract. 2015 Sep-Oct;18(5):693-7. doi: 10.4103/1119-3077.158983. Niger J Clin Pract. 2015. PMID: 26096253 Review.
-
Pituitary resistance to thyroid hormones.Horm Res. 1992;38(1-2):66-72. doi: 10.1159/000182491. Horm Res. 1992. PMID: 1306520 Review.
Cited by
-
Prognostic indicators in pituitary adenoma surgery: a comprehensive analysis of surgical outcomes and complications.Front Endocrinol (Lausanne). 2024 Jan 11;14:1327404. doi: 10.3389/fendo.2023.1327404. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38274233 Free PMC article.
-
Another story of mice and men: the types of RTH.Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9129-30. doi: 10.1073/pnas.0904504106. Epub 2009 Jun 3. Proc Natl Acad Sci U S A. 2009. PMID: 19497872 Free PMC article. No abstract available.
-
Thyrotropin-secreting microadenoma and the importance of a prompt diagnosis: A case report.Hippokratia. 2022 Oct-Dec;26(4):157-160. Hippokratia. 2022. PMID: 37497534 Free PMC article.
-
Effectiveness of long-acting octreotide in suppressing hormonogenesis and tumor growth in thyrotropin-secreting pituitary adenomas: report of two cases.Pituitary. 2001 Aug;4(3):135-43. doi: 10.1023/a:1015358721993. Pituitary. 2001. PMID: 12138986
-
Increased risk of multisystem comorbidities and disease trajectories following hyperthyroidism: evidence from the 0.5 million UK Biobank population.Endocr Connect. 2025 Apr 23;14(5):e250066. doi: 10.1530/EC-25-0066. Print 2025 May 1. Endocr Connect. 2025. PMID: 40193316 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical